OrthoPediatrics Corp. (NASDAQ:KIDS) Stock Now Rated “Moderate Buy” by Wall Street Brokerages

Shares of OrthoPediatrics Corp. (NASDAQ:KIDS) have received a consensus recommendation of “Moderate Buy” from the nine brokerages that are covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and seven have issued a buy recommendation on the company. The average 12 month price objective among brokerages that have issued ratings on the stock in the last year is $30.75.

Several equities analysts have recently commented on KIDS shares. Needham & Company LLC reaffirmed a “buy” rating and set a $35.00 target price on shares of OrthoPediatrics in a report on Wednesday, October 28th. Piper Sandler reissued an “overweight” rating and issued a $30.00 price target (up from $25.00) on shares of OrthoPediatrics in a report on Wednesday, October 28th. Weiss Ratings restated a “sell (d-)” rating on shares of OrthoPediatrics in a research report on Tuesday, November 3rd. BTIG Research boosted their price objective on OrthoPediatrics from $29.00 to $30.00 and gave the company a “buy” rating in a research report on Wednesday, October 28th. Finally, Canaccord Genuity Group upped their price objective on OrthoPediatrics from $28.00 to $30.00 and gave the stock a “buy” rating in a research note on Wednesday, October 28th.

Insider Activity

In related news, major shareholder Squadron Capital Llc sold 302,369 shares of OrthoPediatrics stock in a transaction dated Thursday, September 10th. The stock was sold at an average price of $21.01, for a total transaction of $6,352,772.69. Following the transaction, the insider directly owned 6,201,764 shares of the company’s stock, valued at $130,299,061.64. The trade was a 4.65% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, major shareholder Jennifer Pritzker sold 302,369 shares of the business’s stock in a transaction dated Thursday, September 10th. The stock was sold at an average price of $21.01, for a total transaction of $6,352,772.69. Following the completion of the sale, the insider owned 6,201,764 shares in the company, valued at approximately $130,299,061.64. This trade represents a 4.65% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 2,100,000 shares of company stock worth $46,747,931 over the last 90 days. 32.50% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On OrthoPediatrics

Hedge funds have recently modified their holdings of the stock. GAMMA Investing LLC increased its holdings in shares of OrthoPediatrics by 70.3% in the 3rd quarter. GAMMA Investing LLC now owns 1,165 shares of the company’s stock valued at $26,000 after acquiring an additional 481 shares during the period. Waverly Advisors LLC grew its position in OrthoPediatrics by 6.7% in the 2nd quarter. Waverly Advisors LLC now owns 12,366 shares of the company’s stock valued at $237,000 after buying an additional 775 shares during the last quarter. Legal & General Group Plc purchased a new position in OrthoPediatrics in the 2nd quarter valued at $34,000. Quantinno Capital Management LP purchased a new position in OrthoPediatrics during the 1st quarter worth $160,000. Finally, Advisors Asset Management Inc. purchased a new position in OrthoPediatrics during the 3rd quarter worth $228,000. 69.05% of the stock is currently owned by institutional investors and hedge funds.

OrthoPediatrics Trading Down 0.7%

KIDS stock opened at $32.35 on Monday. The company has a quick ratio of 2.00, a current ratio of 4.55 and a debt-to-equity ratio of 0.29. The company has a market cap of $844.66 million, a price-to-earnings ratio of -22.62 and a beta of 0.90. The business has a fifty day simple moving average of $25.07 and a 200-day simple moving average of $20.30. OrthoPediatrics has a 52 week low of $14.42 and a 52 week high of $34.53.

OrthoPediatrics (NASDAQ:KIDS) last released its quarterly earnings data on Tuesday, October 27th. The company reported ($0.23) earnings per share for the quarter, missing the consensus estimate of ($0.21) by ($0.02). The firm had revenue of $72.66 million during the quarter, compared to analyst estimates of $68.50 million. OrthoPediatrics had a negative net margin of 12.83% and a negative return on equity of 8.10%. On average, equities research analysts expect that OrthoPediatrics will post -1.09 EPS for the current year.

About OrthoPediatrics

OrthoPediatrics Corp. develops and markets orthopedic implants and instruments designed specifically for children and adolescents. Its products support surgeons treating a range of pediatric conditions, including fractures, spinal deformities, limb-length differences and other orthopedic disorders. The company’s portfolio includes systems for trauma and deformity correction, scoliosis treatment, limb lengthening and external fixation, as well as specialized surgical instruments. It also provides related education and support for pediatric orthopedic surgeons and care teams.